Functional imaging for radiotherapy treatment planning: current status and future directions—a review

por Thorwarth, D
Publicado 2015

Estimation of secondary cancer projected risk after partial breast irradiation at the 1.5 T MR-linac

por De-Colle, C., Dohm, O., Mönnich, D., Nachbar, M., Weidner, N., Heinrich, V., Boeke, S., Gani, C., Zips, D., Thorwarth, D.
Publicado 2022

Analysis of the electron-stream effect in patients treated with partial breast irradiation using the 1.5 T MR-linear accelerator

por De-Colle, C., Nachbar, M., Mӧnnich, D., Boeke, S., Gani, C., Weidner, N., Heinrich, V., Winter, J., Tsitsekidis, S., Dohm, O., Zips, D., Thorwarth, D.
Publicado 2021

Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac – Feasibility, workflow data and patient acceptance

por Gani, Cihan, Boeke, S., McNair, H., Ehlers, J., Nachbar, M., Mönnich, D., Stolte, A., Boldt, J., Marks, C., Winter, J., Künzel, Luise A., Gatidis, S., Bitzer, M., Thorwarth, D., Zips, D.
Publicado 2020

Adaptive radiotherapy for breast cancer

por De-Colle, C., Kirby, A., Russell, N., Shaitelman, S.F., Currey, A., Donovan, E., Hahn, E., Han, K., Anandadas, C.N., Mahmood, F., Lorenzen, E.L., van den Bongard, D., Groot Koerkamp, M.L., Houweling, A.C., Nachbar, M., Thorwarth, D., Zips, D.
Publicado 2022

Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial

por Konert, T., Vogel, W. V., Paez, D., Polo, A., Fidarova, E., Carvalho, H., Duarte, P. S., Zuliani, A. C., Santos, A. O., Altuhhova, D., Karusoo, L., Kapoor, R., Sood, A., Khader, J., Al-Ibraheem, A., Numair, Y., Abubaker, S., Soydal, C., Kütük, T., Le, T. A., Canh, N. X., Bieu, B. Q., Ha, L. N., Belderbos, J. S. A., MacManus, M. P., Thorwarth, D., Hanna, G. G.
Publicado 2019